Moreover, initiation of aclidinium as monotherapy maintenance treatment rather than as add-on therapy was associated with higher odds of experiencing an improvement in early-morning and night-time symptoms, even though the latter did not reach statistical significance.
← all excerpts
Effect of aclidinium bromide therapy on quality of life and symptoms of patients with chronic obstructive pulmonary disease: pooled analysis results of the Greek and Austrian ON-AIR real-world observational studies.
1
—
—